drugset / Trial / NCT04125550
Propofol vs Sevoflurane in Cyanotic Congenital Heart Disease
RandomizedParallel-groupDouble-blindPrevention
Summary
The stress response to surgery compromises a series of humoral, metabolic, or cellular reactions. Cardiac surgery with use of cardiopulmonary bypass (CPB) is a major activator of the systemic inflammatory response (SIRS). Inflammation, resulting in neutrophil activation, plays a central role in the production of reactive oxygen species (ROS). Inflammatory and oxidative reactions may play a role in the more frequent observation of postoperative ventricular dysfunction in patients with cyanotic congenital heart disease (CHD) undergoing surgery. The aim of this study is to compare the anti-inflammatory and anti-oxidant effects of propofol and sevoflurane in children with cyanotic CHD undergoing open heart surgery with CPB.
Timeline
- Start
- 2020-01-01
- Primary completion
- 2021-11-01
- Completion
- 2022-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Propofol | Small molecule | 10 mg/kg | — |
| Comparator | Sevoflurane | Other / unclassified | 2 % | Inhaled |